Editor’s Choice: Two-Center Experience in the Endovascular Treatment of Intracranial Aneurysms Using the Woven EndoBridge 17 Device Including Midterm Follow-Up Results: A Retrospective Analysis

Editor’s Choice

In 2016, the smaller Woven EndoBridge 17, with finer size increments that used a 0.017-inch microcatheter, was introduced. The authors retrospectively analyzed their initial and follow-up results with the Woven EndoBridge 17 in ruptured and unruptured aneurysms. Treatment was performed as intended in 124 of 127 cases (97.6%). Additional devices such as stents or coils were used in 12 cases (9.7%). Five thromboembolic complications and 1 hemorrhagic complication were encountered resulting in clinical deterioration in 2 patients. The overall morbidity and mortality in the entire series was 1.7% and 0.0%, respectively. The Woven EndoBridge 17 device is safe in the treatment of small broad-based aneurysms without the general need for additional devices.

BACKGROUND AND PURPOSE

The complete occlusion of an unruptured bilobulated aneurysm of the AcomA in a patient with a history of SAH from another aneurysm.
The complete occlusion of an unruptured bilobulated aneurysm of the AcomA in a patient with a history of SAH from another aneurysm.

The Woven EndoBridge device proved its effectiveness in the treatment of ruptured and unruptured intracranial aneurysms as a stand-alone device. Before 2016, Woven EndoBridge deployment required at least a 0.021-inch microcatheter. In 2016, a smaller device, the Woven EndoBridge 17 with finer size increments that used a 0.017-inch microcatheter, was introduced. We retrospectively analyzed our initial and follow-up results with the Woven EndoBridge 17 in ruptured and unruptured aneurysms.

MATERIALS AND METHODS

One hundred twenty-seven intracranial aneurysms in 117 patients were scheduled for treatment with the Woven EndoBridge 17 between June 2017 and February 2019. Twenty-nine aneurysms were ruptured.

RESULTS

Treatment was performed as intended in 124 of 127 cases (97.6%). Additional devices such as stents or coils were used in 12 cases (9.7%). Five thromboembolic complications and 1 hemorrhagic complication were encountered, resulting in clinical deterioration in 2 patients. The overall morbidity and mortality in the entire series have been 1.7% and 0.0% to date, respectively. The follow-up results at 3 and 12 months revealed complete occlusion in 76.1% (70/92) and 78.0% (32/41).

CONCLUSION

The Woven EndoBridge 17 device is safe in the treatment of small broad-based aneurysms without the general need for additional devices. The low complication rate and the promising follow-up results underline the value of this technique in a growing range of endovascular treatment options for intracranial aneurysms.

Read this article: http://bit.ly/2ZORA1t

Editor’s Choice: Two-Center Experience in the Endovascular Treatment of Intracranial Aneurysms Using the Woven EndoBridge 17 Device Including Midterm Follow-Up Results: A Retrospective Analysis
Jeffrey Ross
Fatal error: Uncaught Error: Call to undefined function get_cimyFieldValue() in /home2/ajnrblog/public_html/wp-content/themes/ample-child/author-bio.php:13 Stack trace: #0 /home2/ajnrblog/public_html/wp-content/themes/ample-child/content-single.php(35): include() #1 /home2/ajnrblog/public_html/wp-includes/template.php(812): require('/home2/ajnrblog...') #2 /home2/ajnrblog/public_html/wp-includes/template.php(745): load_template('/home2/ajnrblog...', false, Array) #3 /home2/ajnrblog/public_html/wp-includes/general-template.php(206): locate_template(Array, true, false, Array) #4 /home2/ajnrblog/public_html/wp-content/themes/ample/single.php(21): get_template_part('content', 'single') #5 /home2/ajnrblog/public_html/wp-includes/template-loader.php(106): include('/home2/ajnrblog...') #6 /home2/ajnrblog/public_html/wp-blog-header.php(19): require_once('/home2/ajnrblog...') #7 /home2/ajnrblog/public_html/index.php(17): require('/home2/ajnrblog...') #8 {main} thrown in /home2/ajnrblog/public_html/wp-content/themes/ample-child/author-bio.php on line 13